Physician profile
Nathan Lee
NPI 1174028633
$64,280.81
in general payments reported to CMS, 2019-2025
9 companies · $9,066 in 2025
The $9,066 reported for 2025 was more than what 87% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $52K · 2024: $3,084 · 2025: $9,066.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $50K · Food and Beverage: $7,673 · Travel and Lodging: $6,608.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $50,000.00 |
| Food and Beverage | $7,672.91 |
| Travel and Lodging | $6,607.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $59,275.61 | 2023-2025 | Synchromedii, Cd Horizon Spinal System, Mazor X System |
| Alphatec Spine, INC | $3,570.18 | 2024-2025 | Other - Miscellaneous, Invictus Mis, Invictus Open |
| Bioventus LLC | $389.62 | 2024-2025 | Bonescalpel & Sonicone (O.R.) |
| Nuvasive, INC. | $310.87 | 2023 | Tlif, Acp, Xlif |
| Surgical Theater. INC. | $210.10 | 2025 | |
| Globus Medical, INC. | $190.34 | 2024 | Excelsius3d Imaging System |
| Axogen | $149.98 | 2023 | Avance Nerve Graft |
| Stryker Corporation | $142.86 | 2023 | Gamma |
| Si-Bone, INC. | $41.25 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.